Western blot analysis revealed that ar-turmerone downregulated the G1/S-phase biomarkers Cyclin-dependent kinase 2 (CDK2), CyclinD1 and upregulated P27 in glioma cells (Figure 3E). Here, CDK2 is linked to central nervous system cancer.